High-resolution spatial transcriptomics through light patterning

通过光图案化的高分辨率空间转录组学

基本信息

  • 批准号:
    9886581
  • 负责人:
  • 金额:
    $ 21.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-03-01 至 2023-02-28
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The cellular composition of a tumor as well as the spatial arrangement of cells within the tumor are major determinants of the response to therapy and the emergence of resistance. To improve our understanding of tumor heterogeneity, accelerate the discovery of new drug targets or enable better patient stratification it is thus necessary to develop tools that can resolve molecularly defined cell types within a tumor and capture their spatial relationships. Driven by progress in single-cell RNA sequencing (scRNA-seq) technologies, a complete census of molecularly defined cell types within a tumor is now within reach. However, because scRNA-seq requires dissociated cells and cannot preserve information about the spatial arrangement of cells in their original context, it gives an incomplete picture of the relationship between gene expression, cell type identity and tumor architecture. The need for technologies that measure gene expression in single cells while retaining position information has long been recognized, but existing solutions have insufficient cellular throughput, spatial resolution, or gene detection sensitivity. We propose to develop Combinatorial Light-Activated Spatial Sequencing (CLASSeq), a transformative approach to spatial transcriptomics that overcomes these limitations. CLASSeq uses patterned light illumination to attach DNA barcodes encoding location information to all cells of interest within a tissue section, with spatial resolution limited only by the wavelength of light. Spatial barcodes are sequenced together with cellular transcriptomes after dissociating the tissue into individual cells or nuclei, and tissue-wide gene expression patterns are computationally recreated. Because sequencing is performed after dissociation, any established scRNA-seq workflow can be used, enabling high sensitivity and cell throughput. To achieve high throughput and reproducibility, and facilitate wide adoption, we will work toward automating the labeling workflow by constructing a prototype instrument that integrates fluidics for barcode delivery with patterned illumination. To validate our approach and demonstrate its utility to cancer research, CLASSeq will be used to characterize cellular diversity and organization in Hodgkin lymphoma, a mature B-cell lymphoma in which the tumor microenvironment niche is critical to the tumor's success for host immune evasion and thus governs the response or lack thereof to clinical immune modulatory therapies.
项目概要 肿瘤的细胞组成以及肿瘤内细胞的空间排列是主要因素 对治疗的反应和耐药性出现的决定因素。为了提高我们对 肿瘤异质性,加速新药靶点的发现或实现更好的患者分层 有必要开发能够解析肿瘤内分子定义的细胞类型并捕获其空间的工具 关系。在单细胞 RNA 测序 (scRNA-seq) 技术进步的推动下,全面的普查 肿瘤内分子定义的细胞类型现在已经可以实现。然而,由于 scRNA-seq 需要 分离的细胞并且无法保留有关细胞在其原始环境中的空间排列的信息, 它对基因表达、细胞类型识别和肿瘤之间的关系给出了不完整的描述 建筑学。需要在保持位置的同时测量单细胞基因表达的技术 信息早已被认可,但现有解决方案的蜂窝吞吐量、空间 分辨率,或基因检测灵敏度。我们建议开发组合光激活空间 测序 (CLASSeq) 是一种空间转录组学的变革性方法,克服了这些限制。 CLASSeq 使用图案光照明将编码位置信息的 DNA 条形码附加到所有细胞上 对组织切片感兴趣,空间分辨率仅受光波长的限制。空间条形码 将组织解离成单个细胞或细胞核后与细胞转录组一起测序, 并通过计算重新创建组织范围的基因表达模式。因为测序是在之后进行的 解离时,可以使用任何已建立的 scRNA-seq 工作流程,从而实现高灵敏度和细胞通量。到 实现高通量和可重复性,并促进广泛采用,我们将努力实现自动化 通过构建原型仪器来构建标签工作流程,该仪器集成了用于条形码传送的流体学 图案照明。为了验证我们的方法并展示其在癌症研究中的实用性,CLASSeq 将 用于表征霍奇金淋巴瘤的细胞多样性和组织,霍奇金淋巴瘤是一种成熟的 B 细胞淋巴瘤,其中 肿瘤微环境生态位对于肿瘤成功逃避宿主免疫至关重要,从而控制着 对临床免疫调节疗法的反应或缺乏。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Georg Seelig其他文献

Georg Seelig的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Georg Seelig', 18)}}的其他基金

Engineering cell type-specific splicing regulation
工程细胞类型特异性剪接调控
  • 批准号:
    10633765
  • 财政年份:
    2023
  • 资助金额:
    $ 21.81万
  • 项目类别:
Joint receptor and protein expression immunophenotyping through split-pool barcoding
通过分池条形码进行联合受体和蛋白质表达免疫表型
  • 批准号:
    10625987
  • 财政年份:
    2021
  • 资助金额:
    $ 21.81万
  • 项目类别:
Joint receptor and protein expression immunophenotyping through split-pool barcoding
通过分池条形码进行联合受体和蛋白质表达免疫表型
  • 批准号:
    10375354
  • 财政年份:
    2021
  • 资助金额:
    $ 21.81万
  • 项目类别:
High-resolution spatial transcriptomics through light patterning
通过光图案化的高分辨率空间转录组学
  • 批准号:
    10341212
  • 财政年份:
    2020
  • 资助金额:
    $ 21.81万
  • 项目类别:
A massively parallel reporter assay for measuring chromatin effects on alternative splicing
用于测量染色质对选择性剪接的影响的大规模并行报告分析
  • 批准号:
    10161803
  • 财政年份:
    2020
  • 资助金额:
    $ 21.81万
  • 项目类别:
A massively parallel reporter assay for measuring chromatin effects on alternative splicing
用于测量染色质对选择性剪接的影响的大规模并行报告分析
  • 批准号:
    9977420
  • 财政年份:
    2020
  • 资助金额:
    $ 21.81万
  • 项目类别:
High-resolution spatial transcriptomics through light patterning
通过光图案化进行高分辨率空间转录组学
  • 批准号:
    10112854
  • 财政年份:
    2020
  • 资助金额:
    $ 21.81万
  • 项目类别:
A predictive model of mRNA stability and translation for variant interpretation and mRNA therapeutics
用于变异解释和 mRNA 治疗的 mRNA 稳定性和翻译的预测模型
  • 批准号:
    9894822
  • 财政年份:
    2018
  • 资助金额:
    $ 21.81万
  • 项目类别:
Predictive Modeling of Alternative Splicing and Polyadenylation from Millions of Random Sequences
数百万随机序列的选择性剪接和聚腺苷酸化的预测模型
  • 批准号:
    9306648
  • 财政年份:
    2017
  • 资助金额:
    $ 21.81万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 21.81万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 21.81万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 21.81万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.81万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 21.81万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 21.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 21.81万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 21.81万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 21.81万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 21.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了